Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling

Human Molecular Genetics

Volumn 18, Issue 11, 2009, Pages 1962-1975

  Sadikovic, Bekim ^a   Yoshimoto, Maisa ^b   Chilton MacNeill, Susan ^a   Thorner, Paul ^a   Squire, Jeremy A ^b   Zielenska, Maria ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOKINE RECEPTOR; DEDICATOR OF CYTOKINESIS 5 PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10A; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10D; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CHROMOSOME 1Q; CHROMOSOME 6P; CHROMOSOME 8P; CHROMOSOME LOSS; CONTROLLED STUDY; DNA METHYLATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC GAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOBLAST; OSTEOSARCOMA; POLYPLOIDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CHROMOSOMES, HUMAN; DNA METHYLATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

EID: 65549107328     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp117     Document Type: Article

References (40)

1. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell 100, 57-70.
2. Sadikovic, B., Al-Romaih, K., Squire, J. and Zielenska, M. (2008) Cause and consequences of genetic and epigenetic alterations in human cancer. Curr. Genomics, 9, 394-408.
3. Kondo, Y., Shen, L., Cheng, A.S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B. et al. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet., 40, 741-750.
4. McLendon, R., Friedman, A., Bigner, D., Van Meir, E.G., Brat, D.J., Mastrogianakis, M., Olson, J.J., Mikkelsen, T., Lehman, N., Aldape, K. et al. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature.
5. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L. et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807-1812.
6. Batanian, J.R., Cavalli, L.R., Aldosari, N.M., Ma, E., Sotelo-Avila, C., Ramos, M.B., Rone, J.D., Thorpe, C.M. and Haddad, B.R. (2002) Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses. Mol. Pathol., 55, 389-393.
7. Lim, G., Karaskova, J., Beheshti, B., Vukovic, B., Bayani, J., Selvarajah, S., Watson, S.K., Lam, W.L., Zielenska, M. and Squire, J.A. (2005) An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma. Genes Chromosomes Cancer, 42, 392-403.
8. Lim, G., Karaskova, J., Vukovic, B., Bayani, J., Beheshti, B., Bernardini, M., Squire, J.A. and Zielenska, M. (2004) Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63. Cancer Genet. Cytogenet., 153, 158-164.
9. Sandberg, A.A. and Bridge, J.A. (2003) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Osteosarcoma and related tumors. Cancer Genet. Cytogenet., 145, 1-30.
10. Squire, J.A., Pei, J., Marrano, P., Beheshti, B., Bayani, J., Lim, G., Moldovan, L. and Zielenska, M. (2003) High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer, 38, 215-225.
11. Zielenska, M., Marrano, P., Thorner, P., Pei, J., Beheshti, B., Ho, M., Bayani, J., Liu, Y., Sun, B.C., Squire, J.A. et al. (2004) High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue. Cytogenet. Genome Res., 107, 77-82.
12. Selvarajah, S., Yoshimoto, M., Maire, G., Paderova, J., Bayani, J., Squire, J.A. and Zielenska, M. (2007) Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization. Cancer Genet. Cytogenet., 179, 52-61.
13. Locklin, R.M., Oreffo, R.O. and Triffitt, J.T. (1998) Modulation of osteogenic differentiation in human skeletal cells in vitro by 5-azacytidine. Cell Biol. Int., 22, 207-215.
14. Ryhanen, S., Pirskanen, A., Jaaskelainen, T. and Maenpaa, P.H. (1997) State of methylation of the human osteocalcin gene in bone-derived and other types of cells. J. Cell. Biochem., 66, 404-412.
15. Villagra, A., Gutierrez, J., Paredes, R., Sierra, J., Puchi, M., Imschenetzky, M., Wijnen, Av.A., Lian, J., Stein, G., Stein, J. et al. (2002) Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. J. Cell. Biochem., 85, 112-122.
16. Harada, K., Toyooka, S., Maitra, A., Maruyama, R., Toyooka, K.O., Timmons, C.F., Tomlinson, G.E., Mastrangelo, D., Hay, R.J., Minna, J.D. et al. (2002) Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene, 21, 4345-4349.
17. Ulaner, G.A., Vu, T.H., Li, T., Hu, J.F., Yao, X.M., Yang, Y., Gorlick, R., Meyers, P., Healey, J., Ladanyi, M. et al. (2003) Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum. Mol. Genet., 12, 535-549.
18. Al-Romaih, K., Sadikovic, B., Yoshimoto, M., Wang, Y., Zielenska, M. and Squire, J.A. (2008) Decitabine-induced demethylation of 5′ CpG island in GADD45A leads to apoptosis in osteosarcoma cells. Neoplasia, 10, 471-480.
19. Al-Romaih, K., Somers, G.R., Bayani, J., Hughes, S., Prasad, M., Cutz, J.C., Xue, H., Zielenska, M., Wang, Y. and Squire, J.A. (2007) Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation. Cancer Cell Int., 7, 14.
20. Sadikovic, B., Yoshimoto, M., Al-Romaih, K., Maire, G., Zielenska, M. and Squire, J.A. (2008) In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma. PLoS ONE, 3, e2834.
21. Bartke, T., Siegmund, D., Peters, N., Reichwein, M., Henkler, F., Scheurich, P. and Wajant, H. (2001) p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene, 20 571-580.
22. Forus, A., Weghuis, D.O., Smeets, D., Fodstad, O., Myklebost, O. and Geurts van Kessel, A. (1995) Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer, 14, 15-21.
23. Henikoff, S. (2008) Nucleosome destabilization in the epigenetic regulation of gene expression. Nat. Rev. Genet., 9, 15-26.
24. Brazier, H., Stephens, S., Ory, S., Fort, P., Morrison, N. and Blangy, A. (2006) Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: Identification of essential genes in osteoclasts. J. Bone Miner. Res., 21, 1387-1398.
25. Gokgoz, N., Wunder, J.S., Mousses, S., Eskandarian, S., Bell, R.S. and Andrulis, I.L. (2001) Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer, 92 2181-2189.
26. Miller, C.W., Aslo, A., Tsay, C., Slamon, D., Ishizaki, K., Toguchida, J., Yamamuro, T., Lampkin, B. and Koeffler, H.P. (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res. 50, 7950-7954.
27. Radig, K., Schneider-Stock, R., Oda, Y., Neumann, W., Mittler, U. and Roessner, A. (1996) Mutation spectrum of p53 gene in highly malignant human osteosarcomas. Gen. Diagn. Pathol., 142, 25-32.
28. Carlo-Stella, C., Lavazza, C., Locatelli, A., Vigano, L., Gianni, A.M. and Gianni, L. (2007) Targeting TRAIL agonistic receptors for cancer therapy. Clin. Cancer Res., 13, 2313-2317.
29. Zielenska, M., Bayani, J., Pandita, A., Toledo, S., Marrano, P., Andrade, J., Petrilli, A., Thorner, P., Sorensen, P. and Squire, J.A. (2001) Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma. Cancer Genet. Cytogenet., 130, 14-21.
30. Lu, X.Y., Lu, Y., Zhao, Y.J., Jaeweon, K., Kang, J., Xiao-Nan, L., Ge, G., Meyer, R., Perlaky, L., Hicks, J. et al. (2008) Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma. Mol. Cancer Res., 6, 937-946.
31. Byers, B.A. and Garcia, A.J. (2004) Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng., 10, 1623-1632.
32. Geoffroy, V., Kneissel, M., Fournier, B., Boyde, A. and Matthias, P. (2002) High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol. Cell. Biol., 22, 6222-6233.
33. Liu, W., Toyosawa, S., Furuichi, T., Kanatani, N., Yoshida, C., Liu, Y., Himeno, M., Narai, S., Yamaguchi, A. and Komori, T. (2001) Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol., 155, 157-166.
34. Schroeder, T.M., Jensen, E.D. and Westendorf, J.J. (2005) Runx2: A master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res. C. Embryo Today, 75, 213-225.
35. Westendorf, J.J., Zaidi, S.K., Cascino, J.E., Kahler, R., van Wijnen, A.J., Lian, J.B., Yoshida, M., Stein, G.S. and Li, X. (2002) Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell. Biol., 22, 7982-7992.
36. Thomas, D.M., Johnson, S.A., Sims, N.A., Trivett, M.K., Slavin, J.L., Rubin, B.P., Waring, P., McArthur, G.A., Walkley, C.R., Holloway, A.J. et al. (2004) Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J. Cell Biol., 167, 925-934.
37. Pratap, J., Lian, J.B., Javed, A., Barnes, G.L., van Wijnen, A.J., Stein, J.L. and Stein, G.S. (2006) Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev., 25, 589-600.
38. Sadikovic, B., Andrews, J., Carter, D., Robinson, J. and Rodenhiser, D.I. (2008) Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells. J. Biol. Chem., 283, 4051-4060.
39. Yoshimoto, M., Cunha, I.W., Coudry, R.A., Fonseca, F.P., Torres, C.H., Soares, F.A. and Squire, J.A. (2007) FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. Br. J. Cancer, 97, 678-685.
40. Ventura, R.A., Martin-Subero, J.I., Jones, M., McParland, J., Gesk, S., Mason, D.Y. and Siebert, R. (2006) FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J. Mol. Diagn., 8, 141-151.